
![]()
Recent News
Cairo, August 8-9, 2010 — Two young Egyptian graduates succeeded in a competition to attend an international seminar in Switzerland, as they won the first and second in a competition held in Egypt by an international drug company. Lamiaa Bahnassawy came first and Farah Attaia came second and both were eligible to attend the international event in Switzerland.
Their colleague Aliaa Mahmud came third, and was not eligible to travel as the competition is bound by two candidates. They are graduates from German University in Cairo (GUC).they talk about their experience and how women can achieve without forgetting their role in society.
Recent Media Releases
July 31, 2008
Two top Egyptian young graduates selected to attend the global Novartis Biotechnology Leadership Camp "BioCamp" in USA
April 1, 2008
Novartis Inaugurates First Multinational Pharmaceutical Global Production Center in Egypt
February 4, 2009
Swiss Vice President Leuthard Kicks Off Novartis First Export Batch To International Markets
For Journalists
Novartis is working with health authorities around the world to develop an H1N1 vaccine.
Visit the Influenza A (H1N1) information center
Novartis was established in Egypt in 1962 as a joint venture company between CIBA, GEIGY, Sandoz and Wander.
Read more about Novartis in Egypt

Media Contacts ›
The Novartis Corporate Media Relations office can be contacted between 8.00 a.m. and 6.00 p.m by telephone.
+202 24567200
For urgent media requests outside office hours, please contact us at the same telephone number or send us an email.
MedAdNews

Novartis has been named the "Most Admired Pharmaceutical Company"
Multimedia Library

The Novartis multimedia library contains photos, images and videos for you to view, download and use.
About Novartis

On March 7th, 1996 Sandoz and Ciba-Geigy, the two Swiss-based chemical/life sciences giants, became Novartis.
Biocamp

Novartis is organizing BioCamp, the pioneering biotechnology seminar for graduate students with high management and leadership potential.